Park Avenue Securities LLC bought a new position in shares of Steris PLC (NYSE:STE) during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 3,465 shares of the medical equipment provider’s stock, valued at approximately $396,000.
A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. Comerica Securities Inc. increased its holdings in Steris by 54.4% during the third quarter. Comerica Securities Inc. now owns 3,489 shares of the medical equipment provider’s stock worth $399,000 after buying an additional 1,230 shares during the last quarter. Los Angeles Capital Management & Equity Research Inc. increased its holdings in Steris by 8.3% during the third quarter. Los Angeles Capital Management & Equity Research Inc. now owns 10,480 shares of the medical equipment provider’s stock worth $1,199,000 after buying an additional 800 shares during the last quarter. WINTON GROUP Ltd acquired a new position in Steris during the third quarter worth $970,000. Meeder Asset Management Inc. increased its holdings in Steris by 129.9% during the third quarter. Meeder Asset Management Inc. now owns 5,387 shares of the medical equipment provider’s stock worth $616,000 after buying an additional 3,044 shares during the last quarter. Finally, Commerce Bank acquired a new position in Steris during the third quarter worth $249,000. Institutional investors and hedge funds own 89.52% of the company’s stock.
STE stock opened at $120.70 on Friday. The company has a debt-to-equity ratio of 0.41, a current ratio of 2.63 and a quick ratio of 2.02. Steris PLC has a one year low of $82.88 and a one year high of $121.67. The firm has a market cap of $9.93 billion, a price-to-earnings ratio of 29.08 and a beta of 1.03.
In other Steris news, VP Karen L. Burton sold 1,300 shares of Steris stock in a transaction on Tuesday, August 14th. The shares were sold at an average price of $114.39, for a total transaction of $148,707.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Walter M. Rosebrough, Jr. sold 10,000 shares of Steris stock in a transaction on Wednesday, November 7th. The stock was sold at an average price of $120.50, for a total transaction of $1,205,000.00. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 45,800 shares of company stock valued at $5,464,727. Company insiders own 2.38% of the company’s stock.
A number of equities analysts recently weighed in on STE shares. Stephens restated a “buy” rating and set a $125.00 target price on shares of Steris in a report on Thursday, August 9th. Zacks Investment Research upgraded shares of Steris from a “sell” rating to a “hold” rating in a report on Tuesday, October 9th. JMP Securities boosted their target price on shares of Steris from $113.00 to $125.00 and gave the stock a “market outperform” rating in a report on Thursday, August 9th. Finally, KeyCorp boosted their target price on shares of Steris from $115.00 to $120.00 and gave the stock an “overweight” rating in a report on Thursday, August 9th. Two equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company. Steris presently has an average rating of “Buy” and a consensus target price of $100.86.
STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions.
See Also: Dividend Aristocrat Index
Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.